A double-blind, placebo-controlled trial of topical 1,25-dihydroxycholecalciferol in psoriasis
- 1 October 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 121 (4) , 493-496
- https://doi.org/10.1111/j.1365-2133.1989.tb15517.x
Abstract
In a double-blind trial of topical 1,25-dihydroxycholecalciferol in 47 patients with psoriasis no benefit was shown compared with placebo.This publication has 12 references indexed in Scilit:
- Active vitamin D3 does not suppress recruitment of G0 cells following injuryBritish Journal of Dermatology, 1988
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- An open study of vitamin D3 treatment in psoriasis vulgarisBritish Journal of Dermatology, 1986
- Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1α, 24-dihydroxycholecalciferolBritish Journal of Dermatology, 1986
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences, 1985
- 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 suppress invitro antibody response to T cell-dependent antigenBiochemical and Biophysical Research Communications, 1985
- Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3*Endocrinology, 1983
- Organ Distribution of the Cytoplasmic 1,25- Dihydroxycholecalciferol Receptor in Various Mouse Tissues*Endocrinology, 1980
- The inhibiting effect of soft paraffin on the Kobner response in psoriasisBritish Journal of Dermatology, 1976